Dear Editor,

The novel and lethal coronavirus disease (COVID-19) outbreak, emerging from Wuhan, China, in the late of 2019, unexpectedly dawned on Western European countries. In France (the fifth most affected country worldwide in terms of COVID-19 deaths toll), the first case of infection was officially confirmed on January 24 and the government announced public health emergency responses by March 17 when the national health care infrastructure began to be overwhelmed. As time elapsed, the preventive measures, including national lockdown, have become sources of overwhelming stress and health-related fears.

Periods of epidemics are sources of severe physical and mental health problems, bouts of negative emotions ([@bib0001]; [@bib0002]) and, relatedly, abrupt disruptions in regular sleep habits/patterns (circadian rhythms). However, very little research has provided evidence-based information on sleep-related disorders as a consequence of epidemics in the past. Ongoing COVID-19 studies are also paying less attention to the risk factors of insomnia ([@bib0004]; [@bib0008]; [@bib0010]). In the present online cross-sectional, observational data, we documented the prevalence of insomnia and its contributing factors in a French general public sample.

The survey was conducted, from May 3 to 16, using an anonymous online questionnaire. The data collection adopted purposive and snowball sampling strategies. Participants completed the Insomnia Severity Index (ISI; [@bib0007]), 4-item UCLA Loneliness scale ([@bib0009]), and provided information on sociodemographics, antecedent of mental and physical health conditions, and COVID-19-related stressful life events. The study procedures complied with the provisions of the Declaration of Helsinki of 1975, as revised in 2008. The protocol study was approved by the Ethics Commission of the Faculty of Psychotherapy and the Faculty of Psychology, Sigmund Freud University (LBP2CFYKAO1BEX87902).

The sample included 556 adult participants (75.5% female) with age ranging from 18 to 87 (*M*age = 30.06 years), 48 of whom were infected by the COVID-19. In respect to the period of data collection, we verified whether participants in the survey before the end of confinement was announced (*n* = 462) and after the announcement (*n* = 94) differed in the outcome variable. No significant difference was found (*p* \> 0.47), then both subgroups were pooled. In the overall sample, the mean total ISI scores was 9.2 (SD = 5.66) with 19.1% meeting the diagnostic criteria of clinical insomnia (ISI ≥ 15). In contrast to [@bib0010] study, neither gender nor living area was associated with insomnia severity, however education attainment did (F\[2, 553\] = 13.87, *p* \< 0.0001, partial eta^2^ = 0.03) such that individuals with postgraduate levels had reported lower levels of insomnia severity than participants with primary and college education levels. Through multivariate logistic regression analyses, we found that while compared with individuals with postgraduate levels, those with undergraduate levels (odds ratio \[OR\] = 2.59, 95%CI: 1.34--5.02) and those attending college (OR = 2.41, 95%CI: 1.05--5.53) were more than twofold at greater risk for developing clinical insomnia. Higher levels of worries about the COVID-19 (OR = 1.39, 95%CI: 1.09--1.78), being infected by the virus (OR = 0.43, 95%CI: 0.19--0.97), pre-existing mental health illness (OR = 1.22, 95%CI: 1.12--1.33), and loneliness (OR = 0.41, 95%CI: 0.23--0.72) increased the likelihood of being diagnosed with clinical insomnia. This model explained 25.1% (Nagelkerke *R* ^2^) of the variance in clinical insomnia, and correctly classified 82.4% of cases.

In this study, the prevalence of clinical insomnia reached the upper worldwide insomnia prevalence, estimated at 3.9% to 22% ([@bib0006]). However, it appeared twice lower than those found by [@bib0010] among a Greek population but close to those found by other researchers ([@bib0004]; [@bib0008]) among Chinese and Italian populations respectively, during the COVID-19 pandemic. Addressing a large set of predictor variables, the present study confirmed COVID-19-related worries and loneliness to be the major contributing factors to clinical insomnia as identified by [@bib0010], in addition to education status, being infected by the virus and pre-existing mental health illness. The ongoing virulent pandemic has caused overwhelming worries related to fear of contamination and, at societal levels, health, economic and financial crisis that may affect sleep habits and quality. Worry provokes uncontrollable cognitive arousal which is one of the major mechanisms inducing anxiety, dysregulation in cardiac rhythm and sleep quality ([@bib0005]). Our findings confirmed the well-established relationship between sleep disturbances and variety of psychiatric and medical conditions. It appeared however in our model that individuals with history of mental health illness were at greater risk. The relationship between loneliness and sleep-related disorders is bidirectional ([@bib0003]), however given the item contents of UCLA Loneliness scale reflecting poor interpersonal functioning it stands to argue that loneliness set out the field for clinical insomnia during the COVID-19 crisis period.
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